News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Abbott Laboratories (ABT) Buy of Solvay Pharmaceuticals, Inc. Drug Unit Wins EU Approval



2/12/2010 7:10:31 AM

Bookmark and Share

Reuters -- U.S. drugmaker Abbott Laboratories secured conditional European Union regulatory approval on Thursday for its acquisition of the drug unit of Solvay, boosting its emerging-market exposure.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES